PL358300A1 - Memnopeptydy, sposób ich wytwarzania i ich zastosowania - Google Patents

Memnopeptydy, sposób ich wytwarzania i ich zastosowania

Info

Publication number
PL358300A1
PL358300A1 PL01358300A PL35830001A PL358300A1 PL 358300 A1 PL358300 A1 PL 358300A1 PL 01358300 A PL01358300 A PL 01358300A PL 35830001 A PL35830001 A PL 35830001A PL 358300 A1 PL358300 A1 PL 358300A1
Authority
PL
Poland
Prior art keywords
preparation
memno peptides
memno
peptides
Prior art date
Application number
PL01358300A
Other languages
English (en)
Other versions
PL206818B1 (pl
Inventor
Laszlo Vertesy
Herbert Kogler
Astrid Markus
Matthias Schiell
Original Assignee
Aventis Pharma Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland Gmbh filed Critical Aventis Pharma Deutschland Gmbh
Publication of PL358300A1 publication Critical patent/PL358300A1/pl
Publication of PL206818B1 publication Critical patent/PL206818B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL358300A 2000-02-29 2001-02-15 Memnopeptydy, sposób ich wytwarzania, ich zastosowanie oraz kompozycja je zawierająca PL206818B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00104114A EP1130027A1 (de) 2000-02-29 2000-02-29 Memno-Peptide, Verfahren zu ihrer Herstellung und Verwendung derselben

Publications (2)

Publication Number Publication Date
PL358300A1 true PL358300A1 (pl) 2004-08-09
PL206818B1 PL206818B1 (pl) 2010-09-30

Family

ID=8167973

Family Applications (1)

Application Number Title Priority Date Filing Date
PL358300A PL206818B1 (pl) 2000-02-29 2001-02-15 Memnopeptydy, sposób ich wytwarzania, ich zastosowanie oraz kompozycja je zawierająca

Country Status (30)

Country Link
US (1) US6627604B2 (pl)
EP (2) EP1130027A1 (pl)
JP (1) JP4787449B2 (pl)
KR (1) KR100997073B1 (pl)
CN (1) CN1274715C (pl)
AR (1) AR029808A1 (pl)
AT (1) ATE313556T1 (pl)
AU (2) AU5031801A (pl)
BR (1) BR0108757A (pl)
CA (1) CA2401032C (pl)
CY (1) CY1105550T1 (pl)
CZ (1) CZ303552B6 (pl)
DE (1) DE60116063T2 (pl)
DK (1) DK1261625T3 (pl)
EE (1) EE05406B1 (pl)
ES (1) ES2254394T3 (pl)
HK (1) HK1052712B (pl)
HR (1) HRP20020703B1 (pl)
HU (1) HU228067B1 (pl)
IL (2) IL151458A0 (pl)
ME (1) MEP59108A (pl)
MX (1) MXPA02007845A (pl)
NO (1) NO329082B1 (pl)
NZ (1) NZ521036A (pl)
PL (1) PL206818B1 (pl)
RU (1) RU2261254C2 (pl)
SI (1) SI1261625T1 (pl)
SK (1) SK287310B6 (pl)
WO (1) WO2001064715A2 (pl)
ZA (1) ZA200206841B (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1308613B1 (it) 1999-02-17 2002-01-09 Pharmacia & Upjohn Spa Acidi grassi essenziali nella prevenzione di eventi cardiovascolari.
EP1130027A1 (de) * 2000-02-29 2001-09-05 Aventis Pharma Deutschland GmbH Memno-Peptide, Verfahren zu ihrer Herstellung und Verwendung derselben
DE10050091A1 (de) * 2000-10-09 2002-04-25 Biotechnolog Forschung Gmbh Casein-Peptidfragmente mit wachstumsbeeinflußender Aktivität auf Zellkulturen
ITMI20010129A1 (it) * 2001-01-25 2002-07-25 Pharmacia & Upjohn Spa Acidi grassi essenziali nella terapia di insufficienza cardiaca e scompenso cardiaco
US7160917B2 (en) * 2002-12-13 2007-01-09 Sanofi-Aventis Deutschland Gmbh Spirobenzofuran lactams and their derivatives, processes for their preparation and use thereof
DE10258650A1 (de) * 2002-12-13 2004-06-24 Aventis Pharma Deutschland Gmbh Neue Spirobenzofuranlactame und ihre Derivate, Verfahren zu ihrer Herstellung und Verwendung derselben
DE202012012998U1 (de) 2011-08-31 2014-06-13 Daniel Elias Bioaktive, regenerative Mischung zur Herstellung eines Ergänzungsnahrungsmittels
US11030144B2 (en) * 2018-12-14 2021-06-08 Texas Instruments Incorporated Peripheral component interconnect (PCI) backplane connectivity system on chip (SoC)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3442815B2 (ja) * 1992-05-13 2003-09-02 第一製薬株式会社 ジアザビシクロアルケン誘導体
WO1995004530A1 (en) * 1993-08-06 1995-02-16 Smithkline Beecham Corporation Endothelin receptor antagonists
JPH07330622A (ja) * 1994-06-06 1995-12-19 Asahi Chem Ind Co Ltd 新規生理活性物質スタキボシンｄ及びその製法
RU2083585C1 (ru) * 1994-12-13 1997-07-10 Волгоградское акционерное общество открытого типа "Химпром" Способ получения метилового эфира n-бензилоксикарбонил-l-аспартил-l-фенилаланина
JPH08283118A (ja) * 1995-04-07 1996-10-29 Kao Corp 美白剤
JPH10251262A (ja) * 1997-01-13 1998-09-22 Mercian Corp プロテアーゼ阻害物質およびその製造方法
DE19731571A1 (de) * 1997-07-23 1999-01-28 Merck Patent Gmbh Endothelin-Rezeptor-Antagonisten
DE19754082A1 (de) * 1997-12-05 1999-06-10 Knoll Ag Methode zur Bekämpfung der Fettleibigkeit
AU1726299A (en) * 1997-12-16 1999-07-05 Genencor International, Inc. Novel egiii-like enzymes, dna encoding such enzymes and methods for producing such enzymes
EP1130027A1 (de) * 2000-02-29 2001-09-05 Aventis Pharma Deutschland GmbH Memno-Peptide, Verfahren zu ihrer Herstellung und Verwendung derselben

Also Published As

Publication number Publication date
EP1261625B1 (en) 2005-12-21
ZA200206841B (en) 2003-07-03
NZ521036A (en) 2004-02-27
CA2401032A1 (en) 2001-09-07
HK1052712A1 (en) 2003-09-26
RU2002125877A (ru) 2004-01-10
NO20024105L (no) 2002-10-28
JP4787449B2 (ja) 2011-10-05
HRP20020703A2 (en) 2004-12-31
EE05406B1 (et) 2011-04-15
ES2254394T3 (es) 2006-06-16
HRP20020703B1 (en) 2011-01-31
IL151458A (en) 2008-08-07
CY1105550T1 (el) 2010-07-28
HUP0204584A3 (en) 2005-09-28
IL151458A0 (en) 2003-04-10
CZ303552B6 (cs) 2012-12-05
ME00379B (me) 2011-05-10
JP2004512257A (ja) 2004-04-22
SK12262002A3 (sk) 2003-02-04
MEP59108A (en) 2011-05-10
RU2261254C2 (ru) 2005-09-27
AU2001250318B2 (en) 2005-09-08
PL206818B1 (pl) 2010-09-30
KR20020077508A (ko) 2002-10-11
NO20024105D0 (no) 2002-08-28
SK287310B6 (sk) 2010-06-07
CN1274715C (zh) 2006-09-13
KR100997073B1 (ko) 2010-11-30
HK1052712B (zh) 2007-01-12
HUP0204584A2 (hu) 2003-04-28
US20010031857A1 (en) 2001-10-18
BR0108757A (pt) 2002-12-10
DK1261625T3 (da) 2006-04-18
WO2001064715A2 (en) 2001-09-07
ATE313556T1 (de) 2006-01-15
WO2001064715A3 (en) 2002-03-21
HU228067B1 (en) 2012-09-28
AU5031801A (en) 2001-09-12
MXPA02007845A (es) 2002-11-29
AR029808A1 (es) 2003-07-16
EP1261625A2 (en) 2002-12-04
CN1406243A (zh) 2003-03-26
DE60116063T2 (de) 2006-08-03
CZ20022904A3 (cs) 2002-11-13
CA2401032C (en) 2012-04-10
DE60116063D1 (de) 2006-01-26
US6627604B2 (en) 2003-09-30
EE200200480A (et) 2004-02-16
NO329082B1 (no) 2010-08-16
EP1130027A1 (de) 2001-09-05
SI1261625T1 (sl) 2006-04-30

Similar Documents

Publication Publication Date Title
TWI319764B (en) Mercaptoacetylamide derivatives, a process for their preparation and their use
AU9181501A (en) Percarboxylated polysaccharides, and a process for their preparation
HUP0102833A3 (en) Cyclosporins, process for preparation thereof and their use
TWI315741B (en) A-isomaltosyltransferase, process for producing the same and use thereof
HUP0301627A3 (en) Glass-ceramics, process for their preparation and use
HUP0300327A3 (en) Percyquinnin, a process for its production and its use as a pharmaceutical
GB0014870D0 (en) Peptides
AU7490401A (en) Neuroprotective peptides
HUP0302295A3 (en) Thienodibenzoazulene derivatives, process for their preparation and use thereof
AU146926S (en) A chair
GB0029777D0 (en) Peptides
IL151458A0 (en) Memno peptides, a process for their preparation and their use
GB0002201D0 (en) Process
HUP0100146A3 (en) 3-(1-hydroxy-pentylidene)-5-nitro-3h-benzofuran-2-one, process for its preparation and use thereof
GB0030309D0 (en) Antibodies,Peptides,Analogs and uses thereof
GB0001825D0 (en) Peptides
HUP0300387A3 (en) A glycopeptide and preparation thereof
HUP0204393A3 (en) Pluraflavins and derivatives thereof, process for their preparation and use thereof
GB0007263D0 (en) Peptides
GB0030059D0 (en) Polypeptides, methods and means
GB0001564D0 (en) Process
EP1295940A4 (en) POLYPEPTIDES, THE APPLICATION THEREOF AND METHOD FOR THE PRODUCTION THEREOF
AU7660601A (en) Pseudo-metalloproteins, their preparation and use
GB0006722D0 (en) Process
GB0007264D0 (en) Peptides

Legal Events

Date Code Title Description
RECP Rectifications of patent specification